Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender effect on rocuronium neuromuscular blockade in patients with epilepsy
ChiCTR1800018980Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rocuronium in epilepsy (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Onset time of rocuronium, Peak time of rocuronium and 1 more. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
rocuronium
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR1800018980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018980.